RED CELL DISTRIBUTION WIDTH IN HEART FAILURE: A MULTIMARKER OF DIFFERENT PATHOPHYSIOLOGICAL PATHWAYS
Nicolas Thibodeau-Jarry, Ellen S. O’Meara(Kaiser Permanente Washington Health Research Institute), Mark Liszkowski(Montreal Heart Institute), Lucie Blondeau(Montreal Heart Institute), Anique Ducharme(Montreal Heart Institute), Normand Racine(Montreal Heart Institute), Simon de Denus(Montreal Heart Institute), Matthew T. White(Alnylam Pharmaceuticals (United States)), Jean‐Lucien Rouleau(Montreal Heart Institute), J. Tardif
Cited by 0
Related Papers
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
|New England Journal of Medicine|2004|1.9k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k